Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.212,57
-0,17%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Eloxx Pharmaceuticals Inc (ELOX) Eloxx Pharmaceuticals Inc (ELOX) Notizie

Eloxx Pharmaceuticals Inc

ELOX
3,82
0,00 (0,00%)
07 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/4/202413:30GLOBEEloxx Pharmaceuticals Provides ELX-02 and ZKN-013 Program..
01/4/202422:02EDGAR2Form NT 10-K - Notification of inability to timely file Form..
29/3/202421:11EDGAR2Form 8-K - Current report
21/3/202419:20EDGAR2Form 25-NSE - Notification filed by national security..
14/3/202421:30EDGAR2Form 8-K - Current report
13/3/202416:42GLOBEAlmirall and Eloxx Pharmaceuticals Enter into Exclusive..
26/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202403:44EDGAR2Form S-3 - Registration statement under Securities Act of..
24/1/202423:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/1/202423:10EDGAR2Form 8-K - Current report
28/12/202322:11EDGAR2Form 8-K - Current report
13/11/202322:15GLOBEEloxx Pharmaceuticals Reports Third Quarter 2023 Financial..
16/10/202323:26EDGAR2Form 8-K - Current report
09/10/202314:00GLOBEEloxx Pharmaceuticals Reports Additional Confirmation that..
20/9/202322:05EDGAR2Form 8-K - Current report
20/9/202319:26EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/9/202314:00GLOBEEloxx Pharmaceuticals Announces $2 Million Registered Direct..
18/9/202314:05EDGAR2Form 8-K - Current report
18/9/202313:00GLOBEEloxx Pharmaceuticals Reports Independent Confirmation of..
15/9/202323:15EDGAR2Form 8-K - Current report
07/9/202316:14EDGAR2Form 8-K - Current report
07/9/202315:00GLOBEEloxx Pharmaceuticals Provides Program Updates on ELX-02 and..
29/8/202322:32EDGAR2Form 8-K - Current report
21/8/202322:50EDGAR2Form 8-K - Current report
14/8/202317:56EDGAR2Form 8-K - Current report
14/8/202314:30GLOBEEloxx Pharmaceuticals Reports Second Quarter 2023 Financial..
14/8/202314:00GLOBEEloxx Pharmaceuticals Reports Drug Response in All Patients..
11/8/202322:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:01EDGAR2Form 8-K - Current report
03/8/202315:26GLOBEEloxx Pharmaceuticals Granted Extension by Nasdaq to Regain..
13/7/202314:43EDGAR2Form 8-K - Current report
10/7/202315:00GLOBEEloxx Pharmaceuticals Announces Publication Demonstrating..
28/6/202315:00GLOBEEloxx Pharmaceuticals Key Opinion Leader Event Highlights..
21/6/202319:30GLOBEEloxx Pharmaceuticals to Host Investor and Analyst Call on..
21/6/202315:00GLOBEEloxx Pharmaceuticals Highlights Recent Alport Syndrome..
14/6/202322:53GLOBEEloxx Pharmaceuticals Announces Final Data Assessment from..
Apertura: Min: Max:
Chiusura: 3,82

La tua Cronologia

NASDAQ
ELOX
Eloxx Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network